Glenmark Life Sciences Limited IPO opened for subscription on Monday, July 27, 2021, and will be closed on Thursday, July 29, 2021.  The IPO of the pharma company kicked off to a good start as the issue was fully subscribed around 12 pm. Maximum participation came from Retail Individual Investors (RIIs). Glenmark Life Sciences Limited IPO comprises fresh issue of equity shares worth Rs 1,060 crore and an offer for sale by existing shareholders worth Rs 453 crore, totaling Rs 1513.60 crore. Glenmark Life Sciences Limited IPO price band is Rs 695 to Rs 720 per equity share and IPO lot size comprises 20 equity shares and in multiples of 20 equity shares thereof.  Minimum investment required for Glenmark Life Sciences Limited IPO is Rs 13,900, while maximum purchase limit on UPI is Rs 2 lakh per transaction, as per the company DRHP (Detailed Red Herring Prospectus) 

See Zee Business Live TV Streaming Below:

https://kosmic.kfintech.com/ipostatus/
Step 2: Now, select IPO Name- Glenmark Life Sciences Limited IPO   
Step 3:  Select the option through which you would want to check allotment status in 'Query By', which is Application No/DPID/Client ID/PAN  
Step 4: Select Application type, which is ABSA or Non-ABSA 
Step 5: Enter Application No (In case you have chosen to check via Application No) and Captcha  
Step 6: Once all relevant field are completed, hit submit to check your IPO Allotment status. 
Glenmark Life Sciences Ltd is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management and diabetes. The Company also manufactures and sells APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas.